Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109314) titled 'Testing a skincare serum ( Demelan Nexa Serum) on healthy people to make sure it doesn t clog pores or cause acne where everyone knows what they are using' on April 24.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: ERIS LIFESCIENCES LIMITED
Intervention:
Intervention1: Demelan Nexa Serum: The product will be applied daily once daily of face for 28 Days
Control Intervention1: NIL: NIL
Recruitment Status: Not Recruiting
Phase: N/A ...